Murray A. Persicke has retired as President of Omega Biotech Corporation. Completing his three year mandate, Omega has been repositioned in the marketplace as a Canadian NHP licensed manufacturing plant of a high grade grape seed extract under the name of Protovin™. Murray A. Persicke will continue under contract with Omega Biotech Corporation as Business Affairs Officer.
Murray A. Persicke announces Dr. David Baker as the new President of Omega Biotech Corporation. As a key stakeholder and Board Chair, Dr. Baker offers an excellent leadership choice as the next President. Dr. Baker has a strong science background, the developer of Omâge Cream and Murray A. Persicke’s full support.
Canadian manufacturers of natural health products, effective January 1, 2006, are required to be licensed under by Canadian legislation under the NHP Directorate. Licensing also certifies Good Manufacturing Practices (GMP) from the NHP licensees. This new NHP barrier to entry in the Canadian Natural Health and Wellness market place offers Omega a unique competitive advantage in the production of its Super Antioxidant product Protovin™ in Canada and Internationally.
Omega Biotech Corporation, NHP License Number 300212, is a fifteen year-old privately owned Canadian company based in Victoria BC, originally established to manufacture the natural health supplement known as PROTOVIN™—a premium grape seed extract antioxidant powder.
Omega Biotech Corporation products include: OMEGAVIN PLUS™, a full spectrum natural antioxidant blend; PROTOVIN BQ ASTRINGENCY REDUCED™, an antioxidant powder that can be used for a wide variety of beverage applications since it does not influence taste, color, or clarity when used in recommended amounts; and OMÂGE™ and SPORT OMÂGE™, a nourishing face and body cream created from a network of bioactive super antioxidants.